Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1622 1625
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17689286 | Methods of treating cancer using a combination of SERD Dosing Regimens | Non-Final OA | Eli Lilly and Company |
| 18004997 | ANTIPERSPIRANT STICK COMPOSITIONS | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 17799149 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING OCULAR DISORDERS | Final Rejection | University of Virginia Patent Foundation |
| 17286797 | TREATMENT OF NEUROLOGICAL DISEASE | Non-Final OA | The University of Sheffield |
| 17436010 | MEDIUM CHAIN TRIGLYCERIDE FORMULATIONS WITH IMPROVED BIOAVAILABILITY AND METHODS RELATED THERETO | Non-Final OA | Cerecin Inc. |
| 18462388 | APPLICATION OF CHANNEL BLOCKER IN PREPARATION OF DRUGS FOR TREATING AND/OR PREVENTING LIVER FIBROSIS | Non-Final OA | Affiliated Hospital of Zunyi Medical University |
| 17949754 | N-PALMITOYLETHANOLAMIDE AND DOCOSAHEXAENOIC ACID FOR USE IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER DEPRESSIVE SYNDROMES | Non-Final OA | EPITECH GROUP S.P.A. |
| 17941531 | NITRATED PSILOCYBIN DERIVATIVES AND METHODS OF USING | Non-Final OA | Enveric Biosciences Canada Inc. |
| 17775269 | TOPICAL DELIVERY OF TOFACITINIB USING IONIC LIQUID | Non-Final OA | CAGE BIO, INC. |
| 17830073 | TREATING COGNITIVE DISORDERS USING TRAPIDIL | Final Rejection | Sinopia Biosciences, Inc. |
| 17760644 | COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR OF AN ANTIAPOPTOTIC BCL-2 FAMILY PROTEIN | Non-Final OA | Aprea Therapeutics AB |
| 17628578 | PROCESS FOR THE PREPARATION OF AMORPHOUS MIDOSTAURIN WITH A LOW CONTENT OF RESIDUAL ORGANIC SOLVENT | Non-Final OA | Procos S.P.A. |
| 17597462 | TRANSDERMAL PERMEATION ENHANCING COMPOSITION AND APPLICATION THEREOF IN TIMOLOL PREPARATION | Non-Final OA | WUHAN CONFORM PHARMACEUTICAL CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy